Skip to main content
. 2022 Jan 6;42(1):BSR20211783. doi: 10.1042/BSR20211783

Figure 7. The relationship of MTHFD1L expression with different clinicopathological features of UCEC.

Figure 7

(A) Expression of MTHFD1L in different cancer stages of UCEC patients, (B) expression of MTHFD1L in different races of UCEC patients, (C) expression of MTHFD1L in different genders of UCEC patients, and (D) expression of MTHFD1L in different age groups of UCEC patients. *P<0.05.